|
|
|
|
|
|
|
|
|
Statement of financial position |
|
2026 |
2025 |
|||
|
Note |
£ |
£ |
£ |
£ |
|
Investments |
5 |
|
|
||
|
--------- |
--------- |
||||
|
Total assets less current liabilities |
|
|
|||
|
--------- |
--------- |
||||
|
Called up share capital |
|
|
||
|
Capital redemption reserve |
|
|
||
|
--------- |
--------- |
|||
|
Shareholders funds |
|
|
||
|
--------- |
--------- |
|||
|
|
|
Director |
|
|
|
Notes to the financial statements |
|
Shares in group undertakings |
|
|
£ |
|
|
Cost |
|
|
At 1 April 2025 and 31 March 2026 |
|
|
--------- |
|
|
Impairment |
|
|
At 1 April 2025 and 31 March 2026 |
– |
|
--------- |
|
|
Carrying amount |
|
|
At 31 March 2026 |
|
|
--------- |
|
|
At 31 March 2025 |
|
|
--------- |
|
|
Class of share |
Percentage of shares held |
|
|
Subsidiary undertakings |
||
|
|
Ordinary |
100 |
|
Capital and reserves |
Profit/(loss) for the year |
|||
|
2026 |
2025 |
2026 |
2025 |
|
|
£ |
£ |
£ |
£ |
|
|
Subsidiary undertakings |
||||
|
|
– |
2,015,792 |
– |
169,246 |
|
---- |
----------- |
---- |
--------- |
|